Abstract
High-throughput drug screening (HTS) is a powerful tool that can be used rapidly to identify new potential bacterial inhibitors and/or compounds which enhance host cell control of pathogens, which can then go on to be developed as novel therapeutics. Typically screening is commonly done in artificial culture medium; however, obligate intracellular pathogens, such as Chlamydia trachomatis, cannot be tested this way. Intracellular screening methods allow for such pathogens to undergo HTS, while still giving reliable and consistent data. Plus, as well as identifying new potential bacterial inhibitors, it is also able to detect compounds which enhance host cell control of pathogens, to allow for host-directed therapies to be developed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO. Global incidence and prevalence of selected curable sexually transmitted infections—2008. https://www.who.int/reproductivehealth/publications/rtis/stisestimates/en/
WHO. Prevalence and incidence of selected sexually transmitted infections. https://www.who.int/reproductivehealth/publications/rtis/9789241502450/en/
Mylonas I (2012) Female genital Chlamydia trachomatis infection: where are we heading? Arch Gynecol Obstet 285:1271–1285
Mariotti SP, Pascolini D, Rose-Nussbaumer J (2009) Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 93:563–568
Blandford JM, Gift TL (2006) Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women. Sex Transm Dis 33:S117–S121
Burton MJ, Mabey DCW (2009) The global burden of trachoma: a review. PLoS Negl Trop Dis 3:e460
Somani J, Bhullar VB, Workowski KA, Farshy CE, Black CM (2000) Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 181(4):1421–1427. https://doi.org/10.1086/315372
Wickstrum J, Sammons LR, Restivo KN, Hefty PS (2013) Conditional gene expression in Chlamydia trachomatis using the tet system. PLoS One 8(10):e76743. https://doi.org/10.1371/journal.pone.0076743
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Brown, A.C., Kushner, N.L. (2019). High-Throughput Screening for Novel Inhibitors of Intracellular Pathogens, Including Chlamydia trachomatis. In: Brown, A. (eds) Chlamydia trachomatis. Methods in Molecular Biology, vol 2042. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9694-0_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9694-0_18
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9693-3
Online ISBN: 978-1-4939-9694-0
eBook Packages: Springer Protocols